These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 26470845)
1. Tumor suppressor ASXL1 is essential for the activation of INK4B expression in response to oncogene activity and anti-proliferative signals. Wu X; Bekker-Jensen IH; Christensen J; Rasmussen KD; Sidoli S; Qi Y; Kong Y; Wang X; Cui Y; Xiao Z; Xu G; Williams K; Rappsilber J; Sønderby CK; Winther O; Jensen ON; Helin K Cell Res; 2015 Nov; 25(11):1205-18. PubMed ID: 26470845 [TBL] [Abstract][Full Text] [Related]
2. Deregulation of tumor suppressive ASXL1-PTEN/AKT axis in myeloid malignancies. Cao L; Xia X; Kong Y; Jia F; Yuan B; Li R; Li Q; Wang Y; Cui M; Dai Z; Zheng H; Christensen J; Zhou Y; Wu X J Mol Cell Biol; 2020 Sep; 12(9):688-699. PubMed ID: 32236560 [TBL] [Abstract][Full Text] [Related]
3. The BAP1/ASXL2 Histone H2A Deubiquitinase Complex Regulates Cell Proliferation and Is Disrupted in Cancer. Daou S; Hammond-Martel I; Mashtalir N; Barbour H; Gagnon J; Iannantuono NV; Nkwe NS; Motorina A; Pak H; Yu H; Wurtele H; Milot E; Mallette FA; Carbone M; Affar el B J Biol Chem; 2015 Nov; 290(48):28643-63. PubMed ID: 26416890 [TBL] [Abstract][Full Text] [Related]
4. Cancer-associated ASXL1 mutations may act as gain-of-function mutations of the ASXL1-BAP1 complex. Balasubramani A; Larjo A; Bassein JA; Chang X; Hastie RB; Togher SM; Lähdesmäki H; Rao A Nat Commun; 2015 Jun; 6():7307. PubMed ID: 26095772 [TBL] [Abstract][Full Text] [Related]
6. Tumor-derived neomorphic mutations in ASXL1 impairs the BAP1-ASXL1-FOXK1/K2 transcription network. Xia YK; Zeng YR; Zhang ML; Liu P; Liu F; Zhang H; He CX; Sun YP; Zhang JY; Zhang C; Song L; Ding C; Tang YJ; Yang Z; Yang C; Wang P; Guan KL; Xiong Y; Ye D Protein Cell; 2021 Jul; 12(7):557-577. PubMed ID: 32683582 [TBL] [Abstract][Full Text] [Related]
7. SWI/SNF mediates polycomb eviction and epigenetic reprogramming of the INK4b-ARF-INK4a locus. Kia SK; Gorski MM; Giannakopoulos S; Verrijzer CP Mol Cell Biol; 2008 May; 28(10):3457-64. PubMed ID: 18332116 [TBL] [Abstract][Full Text] [Related]
8. Epigenetic regulation of the INK4b-ARF-INK4a locus: in sickness and in health. Popov N; Gil J Epigenetics; 2010; 5(8):685-90. PubMed ID: 20716961 [TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA, polycomb, and the ghosts haunting INK4b-ARF-INK4a expression. Aguilo F; Zhou MM; Walsh MJ Cancer Res; 2011 Aug; 71(16):5365-9. PubMed ID: 21828241 [TBL] [Abstract][Full Text] [Related]
10. MSK1 triggers the expression of the INK4AB/ARF locus in oncogene-induced senescence. Culerrier R; Carraz M; Mann C; Djabali M Mol Biol Cell; 2016 Sep; 27(17):2726-34. PubMed ID: 27385346 [TBL] [Abstract][Full Text] [Related]
11. Cellular response to oncogenic ras involves induction of the Cdk4 and Cdk6 inhibitor p15(INK4b). Malumbres M; Pérez De Castro I; Hernández MI; Jiménez M; Corral T; Pellicer A Mol Cell Biol; 2000 Apr; 20(8):2915-25. PubMed ID: 10733595 [TBL] [Abstract][Full Text] [Related]
12. PR-DUB maintains the expression of critical genes through FOXK1/2- and ASXL1/2/3-dependent recruitment to chromatin and H2AK119ub1 deubiquitination. Kolovos P; Nishimura K; Sankar A; Sidoli S; Cloos PA; Helin K; Christensen J Genome Res; 2020 Aug; 30(8):1119-1130. PubMed ID: 32747411 [TBL] [Abstract][Full Text] [Related]
13. ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression. Abdel-Wahab O; Adli M; LaFave LM; Gao J; Hricik T; Shih AH; Pandey S; Patel JP; Chung YR; Koche R; Perna F; Zhao X; Taylor JE; Park CY; Carroll M; Melnick A; Nimer SD; Jaffe JD; Aifantis I; Bernstein BE; Levine RL Cancer Cell; 2012 Aug; 22(2):180-93. PubMed ID: 22897849 [TBL] [Abstract][Full Text] [Related]
14. Structural basis of histone H2A lysine 119 deubiquitination by Polycomb repressive deubiquitinase BAP1/ASXL1. Thomas JF; Valencia-Sánchez MI; Tamburri S; Gloor SL; Rustichelli S; Godínez-López V; De Ioannes P; Lee R; Abini-Agbomson S; Gretarsson K; Burg JM; Hickman AR; Sun L; Gopinath S; Taylor HF; Sun ZW; Ezell RJ; Vaidya A; Meiners MJ; Cheek MA; Rice WJ; Svetlov V; Nudler E; Lu C; Keogh MC; Pasini D; Armache KJ Sci Adv; 2023 Aug; 9(32):eadg9832. PubMed ID: 37556531 [TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene. Kotake Y; Nakagawa T; Kitagawa K; Suzuki S; Liu N; Kitagawa M; Xiong Y Oncogene; 2011 Apr; 30(16):1956-62. PubMed ID: 21151178 [TBL] [Abstract][Full Text] [Related]
16. Mutant ASXL1 cooperates with BAP1 to promote myeloid leukaemogenesis. Asada S; Goyama S; Inoue D; Shikata S; Takeda R; Fukushima T; Yonezawa T; Fujino T; Hayashi Y; Kawabata KC; Fukuyama T; Tanaka Y; Yokoyama A; Yamazaki S; Kozuka-Hata H; Oyama M; Kojima S; Kawazu M; Mano H; Kitamura T Nat Commun; 2018 Jul; 9(1):2733. PubMed ID: 30013160 [TBL] [Abstract][Full Text] [Related]
17. Retracted: Histone H2B ubquitination regulates retinoic acid signaling through the cooperation of ASXL1 and BAP1. Lee SW; Youn H; Kim EJ; Um SJ Mol Cell; 2013 Jul; 51(2):200-10. PubMed ID: 23850490 [TBL] [Abstract][Full Text] [Related]
18. Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc. Haviernik P; Schmidt M; Hu X; Wolff L Oncogene; 2003 Mar; 22(11):1600-10. PubMed ID: 12642863 [TBL] [Abstract][Full Text] [Related]
19. Enhancer of zeste homolog 2 depletion induces cellular senescence via histone demethylation along the INK4/ARF locus. Jie B; Weilong C; Ming C; Fei X; Xinghua L; Junhua C; Guobin W; Kaixiong T; Xiaoming S Int J Biochem Cell Biol; 2015 Aug; 65():104-12. PubMed ID: 26004298 [TBL] [Abstract][Full Text] [Related]
20. Loss of BAP1 function leads to EZH2-dependent transformation. LaFave LM; Béguelin W; Koche R; Teater M; Spitzer B; Chramiec A; Papalexi E; Keller MD; Hricik T; Konstantinoff K; Micol JB; Durham B; Knutson SK; Campbell JE; Blum G; Shi X; Doud EH; Krivtsov AV; Chung YR; Khodos I; de Stanchina E; Ouerfelli O; Adusumilli PS; Thomas PM; Kelleher NL; Luo M; Keilhack H; Abdel-Wahab O; Melnick A; Armstrong SA; Levine RL Nat Med; 2015 Nov; 21(11):1344-9. PubMed ID: 26437366 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]